Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
10 results
  • Liver Cancer, Gastric (Stomach) Cancer, Cervical Cancer

20-577          Phase I

A First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors (View details on

  • Gastric (Stomach) Cancer

17-489          Phase I

A Phase 1 Open-label Dose Escalation and Dose Expansion Study of CGX1321 in Subjects with Advanced Solid Tumors and Phase 1b Study of CGX1321 in Combination with Pembrolizumab in Subjects with Advanced Gastrointestinal Tumors (View details on

  • Brain Tumors, Metastatic, Liver Cancer, Esophageal Cancer, Gastric (Stomach) Cancer, Metastatic/Advanced Cancer, Lung Cancer

19-812          Phase I

A Phase 1, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0022, a novel MET/CSF1R/SRC inhibitor, in Patients with Advanced Solid Tumors Harboring Genetic Alterations in MET (View details on

  • Gastric (Stomach) Cancer, Esophageal Cancer, Breast Cancer, Lung Cancer

20-208          Phase I

A Phase 1/1B, Open-Label, Dose Escalation and Expansion Study of SBT6050 in Subjects With Advanced Solid Tumors Expressing HER2 (View details on

  • Pancreatic Cancer, Esophageal Cancer, Sarcoma, Endometrial Cancer, Bladder Cancer, Gastric (Stomach) Cancer, Liver Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation (View details on

  • Gastric (Stomach) Cancer, Esophageal Cancer

20-433          Phase II

A Phase 2a, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab +/-Chemotherapy as First- Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Distinguish) (View details on

  • Head and Neck Cancer, Gastric (Stomach) Cancer, Esophageal Cancer, Lung Cancer, Colorectal Cancer

19-431          Phase I

A Phase Ib, open-label, multi-center study to characterize the safety, tolerability, and preliminary efficacy of TNO155 in combination with spartalizumab or ribociclib in selected malignancies (View details on

  • Gastric (Stomach) Cancer, Esophageal Cancer, Bladder Cancer, Lung Cancer

20-248          Phase II

Phase 1/2 study of APR-246 in Combination with Pembrolizumab in Subjects with Solid Tumor Malignancies (View details on

  • Colorectal Cancer, Gastric (Stomach) Cancer, Kidney Cancer

19-593          Phase I

Phase Ib study of gevokizumab in combination with standard of care anti-cancer therapies in patients with metastatic colorectal cancer, gastroesophageal cancer and renal cell carcinoma (View details on

  • Colorectal Cancer, Gastric (Stomach) Cancer, Hematology

19-685          Phase III

RECITE: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer (View details on

Showing 1 - 10 of 10 results